Anthony H. Gershlick, Leicester University
Abstract: N Engl J Med 2005; 353:2758
If your patient with myocardial infarction has been treated with thrombolysis as primary therapy, and if reperfusion is not successful, it is more effective to use percutaneous coronary intervention to rescue the patient rather than repeat throbolysis or conservative management. That’s according to the REACT trial published in the New England Journal of Medicine. Peter Goodwin visited the Glenfield Hospital in Leicester to ask REACT trial principal investigator, Tony Gershlick, about the clinical implications of this analysis of results from this multicentre trial in the UK with 427 patients.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.